Eyenovia Inc (EYEN)
1.01
+0.07
(+7.74%)
USD |
NASDAQ |
May 03, 16:00
1.02
+0.01
(+0.99%)
After-Hours: 20:00
Eyenovia Total Assets (Quarterly): 28.78M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 28.78M |
| September 30, 2023 | 34.87M |
| June 30, 2023 | 29.35M |
| March 31, 2023 | 29.31M |
| December 31, 2022 | 31.04M |
| September 30, 2022 | 31.41M |
| June 30, 2022 | 35.61M |
| March 31, 2022 | 40.19M |
| December 31, 2021 | 31.66M |
| September 30, 2021 | 24.99M |
| June 30, 2021 | 30.58M |
| March 31, 2021 | 28.85M |
| December 31, 2020 | 33.91M |
| September 30, 2020 | 25.85M |
| Date | Value |
|---|---|
| June 30, 2020 | 11.43M |
| March 31, 2020 | 14.91M |
| December 31, 2019 | 14.70M |
| September 30, 2019 | 18.88M |
| June 30, 2019 | 10.04M |
| March 31, 2019 | 15.03M |
| December 31, 2018 | 20.02M |
| September 30, 2018 | 21.47M |
| June 30, 2018 | 24.82M |
| March 31, 2018 | 27.98M |
| December 31, 2017 | 5.643M |
| September 30, 2017 | 7.689M |
| December 31, 2016 | 3.433M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
10.04M
Minimum
Jun 2019
40.19M
Maximum
Mar 2022
26.65M
Average
29.31M
Median
Mar 2023
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 9.034M |
| Alpine Immune Sciences Inc | 379.85M |
| Lantern Pharma Inc | 43.65M |
| Oragenics Inc | 4.966M |
| MAIA Biotechnology Inc | 7.567M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 19.78M |
| Shareholders Equity (Quarterly) | 8.999M |
| Debt to Equity Ratio | 1.588 |
| Current Ratio | 2.173 |
| Net Debt Paydown Yield | -1.49% |